clonazepam has been researched along with Dysarthosis in 1 studies
Clonazepam: An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses.
clonazepam : 1,3-Dihydro-2H-1,4-benzodiazepin-2-one in which the hydrogens at positions 5 and 7 are substituted by 2-chlorophenyl and nitro groups, respectively. It is used in the treatment of all types of epilepsy and seizures, as well as myoclonus and associated abnormal movements, and panic disorders. However, its use can be limited by the development of tolerance and by sedation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clonazepam has a definite role in the management of parkinsonian dysarthria." | 2.66 | A double-blind trial of clonazepam in the treatment of parkinsonian dysarthria. ( Biary, N; Langenberg, PW; Pimental, PA, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biary, N | 1 |
| Pimental, PA | 1 |
| Langenberg, PW | 1 |
1 trial available for clonazepam and Dysarthosis
| Article | Year |
|---|---|
A double-blind trial of clonazepam in the treatment of parkinsonian dysarthria.
Topics: Aged; Clinical Trials as Topic; Clonazepam; Double-Blind Method; Dysarthria; Humans; Middle Aged; Pa | 1988 |